Sonio, a French start-up founded in 2020, has announced a €5 million financing round with the objective of developing an artificial intelligence software that will allow fetal medicine professionals to securely monitor pregnancies.
This round of financing will enable Sonio to accelerate its entry into the US market and accelerate sales in Europe.
The company has brought together unique expertise in the fields of fetal medicine, artificial intelligence, software development and imaging to address the 50% of congenital malformations that go undetected before birth.
This round of financing will enable Sonio to accelerate its entry into the US market and accelerate sales in Europe.
The company has brought together unique expertise in the fields of fetal medicine, artificial intelligence, software development and imaging to address the 50% of congenital malformations that go undetected before birth.